Core Viewpoint - TianTu Investment's third healthcare fund is currently in fundraising, highlighting the firm's ongoing commitment to the healthcare sector and its strategic investments in high-potential companies like Zhuozheng Medical [2][5]. Group 1: Company Overview - Zhuozheng Medical Holdings Limited is set to be listed on the Hong Kong Stock Exchange on February 6, 2026, under the stock code "2677" [3]. - It is recognized as the private mid-to-high-end comprehensive medical service institution group with the widest coverage in Chinese cities, having attracted investments from notable firms including TianTu Investment and others [3]. Group 2: Investment Strategy - TianTu Investment led Zhuozheng Medical's C round financing in 2017 and has been a key institutional investor, providing ongoing support in strategic areas such as brand positioning and resource integration [4]. - The firm has identified the growing demand for high-quality medical services driven by rising living standards, positioning mid-to-high-end private medical services as a long-term investment opportunity [5]. Group 3: Business Model and Growth Potential - Zhuozheng Medical has developed a comprehensive service model that includes multiple specialties, focusing on a family doctor-centered membership plan to enhance user engagement and service frequency [4]. - The company is expected to benefit from trends such as refined parenting, aging population, and increasing family healthcare needs, which will expand the medical service market and accelerate its growth [5]. Group 4: Broader Investment Landscape - Beyond healthcare services, TianTu Investment is also exploring opportunities in innovative pharmaceuticals and synthetic biology, supported by two healthcare-themed funds that have facilitated the rapid growth of several high-potential companies [5]. - The firm has established a multi-strategy investment matrix centered on "consumption + technology," aiming to support companies' stable development and value enhancement through long-term capital and professional post-investment empowerment [5].

Core Viewpoint - Zhuozheng Medical has successfully launched its IPO, attracting significant investor interest in a challenging private healthcare market, with a focus on high-end comprehensive medical services [1][2]. Industry Overview - The private healthcare sector has experienced a slowdown, leading to a clear divide where leading companies continue to grow while smaller institutions face challenges and exit the market [1]. - The industry is undergoing a reshaping phase, with a trend of "the strong getting stronger and the weak being eliminated" [1]. Company Performance - Zhuozheng Medical reported a compound annual growth rate (CAGR) of 42.2% in revenue from 2022 to 2024, with gross profit growth reaching 126.7% [1][6]. - The company achieved profitability in 2024, with adjusted net profit exceeding 10 million yuan in the first eight months of 2025 [1][6]. Business Model - The company operates a unique membership-based model centered around family doctors, likened to "Costco in the healthcare sector," which promotes high-frequency healthcare consumption [3][4]. - Zhuozheng Medical focuses on high-frequency, long-cycle healthcare services, covering a wide range of specialties from pediatrics to geriatrics, thus avoiding competition with public hospitals in low-frequency, high-acuity cases [3][4]. Customer Engagement - The company has established long-term relationships between patients and family doctors, enhancing user loyalty and retention [4]. - Key metrics indicate that in 2024, Zhuozheng Medical had approximately 240,000 clients, with total visits reaching 900,000, averaging nearly four visits per client [4]. Financial Health - Zhuozheng Medical's revenue grew from 470 million yuan to 960 million yuan from 2022 to 2024, with a significant increase in operating cash flow over the same period [6][7]. - The company maintains a low dependency on insurance payments, with over 85% of revenue generated from cash payments, providing a buffer against policy fluctuations [7]. Market Position - The company is strategically positioned in the high-end healthcare market, targeting affluent consumers who prefer personalized medical services [9]. - Zhuozheng Medical operates 19 healthcare facilities across ten major cities in China and has expanded into overseas markets like Singapore and Malaysia [9]. Team and Technology - The company boasts a highly qualified team of 387 full-time doctors, with an average of 15 years of clinical experience, primarily sourced from top-tier hospitals [10]. - Zhuozheng Medical is integrating AI into its service offerings, enhancing operational efficiency and patient care [10]. Conclusion - Zhuozheng Medical's unique business model and strategic focus on high-quality, personalized healthcare services position it as a rare investment opportunity in the private healthcare sector, especially as the industry shifts towards quality over scale [11].